792 J ournal of Natural Products, 1997, Vol. 60, No. 8
Diker et al.
presence of tryptamine to give the tricyclic amide 8
(58%) that was reduced with LiAlH4 in THF to yield
the nazlinine analogue 9 (64%). Treatment with methyl
3-formylpropanoate gave lactam 10 (42%) that was at
last reduced with LiAlH4 in THF to give 7 (54%).
The above results then illustrate some syntheses of
tetrahydro-â-carbolines through catalytic hydrogenation
of nitriles in the presence of tryptamine, as an efficient
substitute to the Pictet-Spengler cyclization.
afford 178 mg (79%) of (()-nazlinine (4): UV (MeOH)
λmax 222, 272, 279, 289 nm; IR (film) νmax 3352, 3225,
3063, 2926, 1674, 1454, 1435, 1201, 1141, 800, 723 cm-1
;
EIMS m/ z 243 [M]+ (30), 197 (11), 185 (24), 171 (100),
154 (15), 144 (26); 1H NMR (CDCl3) δ 1.4-1.8 (7H, m),
2.54-2.72 (6H, m), 2.94 (1H, m), 3.27 (1H, m), 3.95 (1H,
m), 7.07 (2H, m), 7.26 (1H, d, J ) 8 Hz), 7.43 (1H, d, J
) 8 Hz), 9.28 (1H, s); 13C NMR (CDCl3) δ 22.4, 22.7,
32.4, 34.3, 41.2, 42.2, 52.3, 108.1, 110.6, 117.6, 118.7,
120.9, 127.2, 135.6, 136.2.
Exp er im en ta l Section
1-[2-(2,3,4,9-Tetr ah ydr o-1H-â-car bolin -1-yl)eth yl]-
p yr r olid in -2-on e (6). 6 was prepared according to the
procedure utilized for compound 2 using 480 mg (3
mmol) of tryptamine 414 mg (3 mmol) of N-(cyanoethyl)-
pyrrolidone and 64 mg (0.06 mmol) of 10% Pd‚C. After
hydrogenation (48 h), compound 6 was isolated as an
oil (650 mg, 76%). 6: UV (MeOH) λmax 226, 282, 290
nm; IR (film) νmax 3406, 3275, 3111, 3055, 2941, 2854,
Gen er a l Exp er im en ta l P r oced u r es. IR spectra
were recorded on a Bomem spectrometer, and UV
spectra on a Philips Unicam 8700 spectrophotometer.
1H (300 MHz) and 13C (75 MHz) NMR spectra were
measured on a Brucker AC300 spectrometer with TMS
as internal standard. Chemical shifts are reported in ∂
ppm. J values are given in. Mass spectra were re-
corded on an Autospec (VG Instruments). Separations
were carried out on TLC plates with Kieselgel 60 PGF254
(Merck no. 7749), using CH2Cl2/MeOH.
1666, 1494, 1452, 1315, 1298, 1267, 1163, 1116 cm-1
;
EIMS m/ z 283 [M]+ (34), 197 (10), 185 (13), 171 (100),
1
144 (13); H NMR (CDCl3) δ 1.83 (4H, m), 2.3 (2H, t, J
) 9 Hz), 2.57 (1H, s), 2.68 (2H, m), 3.0-3.2 (4H, m),
3.35 (1H, m), 3.76 (2H, m), 7.02 (1H, t, J ) 9 Hz), 7.08
(1H, t, J ) 9 Hz), 7.33 (1H, d, J ) 9 Hz), 7.43 (1H, d, J
) 9 Hz), 10.25 (1H, s); 13C NMR (CDCl3) δ 17.7, 22.1,
30.5, 32.4, 39.5, 40.5, 46.9, 48.6, 107.3, 110.7, 117.3,
118.3, 120.7, 126.8, 135.1, 135.4, 175.6.
4-(2,3,4,9-Tetr ah ydr o-1H-â-car bolin -1-yl)bu tyr on i-
tr ile (2). To a solution of tryptamine (800 mg, 5 mmol)
in 10 mL of glacial acetic acid were added glutaronitrile
(700 mg, 7.5 mmol) and 266 mg of 10% Pd‚C in one
portion. The mixture was hydrogenated at room tem-
perature and atmospheric pressure for 48 h. The
catalyst was removed by filtration through Celite and
washed with CH2Cl2. The resulting solution was made
basic with aqueous NH3 and then extracted with
CH2Cl2. The combined CH2Cl2 solutions were dried on
MgSO4, and the solvent was evaporated. The residue
was purified by Si gel chromatography using CH2Cl2-
MeOH (96:4) as eluent to give 696 mg of 2 (58%) and
159 mg of 3 (14%). 2: UV (MeOH) λmax 222, 282, 291
nm; IR (film) νmax 3402, 3227, 2933, 2854, 2806, 2247,
1620, 1456, 1352, 1232, 1153, 1116, 742 cm-1; EIMS
m/ z 239 [M]+ (33), 171 (100), 156 (19), 144 (15); 1H NMR
(CDCl3) δ 1.7-1.98 (4H, m), 2.35 (4H, m), 2.7 (2H, m),
2.97-3.01 (1H, dt, J ) 5.8, 13.5 Hz), 3.24-3.28 (1H, dt,
J ) 5.8, 13.5 Hz), 4.02 (1H, m), 7.08 (1H, t, J ) 7.6 Hz),
7.13 (1H, t, J ) 7.6 Hz), 7.31 (1H, d, J ) 7.6 Hz), 7.47
(1H, d, J ) 7.6 Hz), 8.52 (1H, s); 13C NMR (CDCl3) δ
16.9, 21.4, 22.4, 33.1, 42.0, 51.6, 108.8, 110.8, 117.9,
119.1, 119.8, 121.4, 127.1, 135.0, 135.6. 3: UV (MeOH)
λmax 231, 282, 290 nm; IR (film) νmax 3398, 3200, 3057,
2937, 2849, 2806, 2760, 1466, 1450, 1346, 1321, 1275,
1211, 1184, 1141, 1109, 738 cm-1; EIMS m/ z 225 [M]+
(91), 197 (35), 169 (33), 156 (18), 143 (17), 130 (15), 115
(16), 82 (100); 1H NMR (CDCl3) δ 1.4-1.6 (2H, m), 1.69-
1.84 (3H, m), 2.2 (2H, m), 2.33-2.41 (1H, m), 2.59-2.73
(2H, m), 2.95-3.1 (3H, m), 3.2 (1H, m), 7.08 (2H, m),
7.27 (1H, d, J ) 9 Hz), 7.44 (1H, d, J ) 9 Hz), 7.98 (1H,
s); 13C NMR (CDCl3) δ 21.5, 24.2, 25.6, 29.8, 53.4, 55.6,
60.1, 107.9, 110.6, 117.9, 119.2, 121.1, 127.4, 135.1,
135.9.
2-(2,3,4,9-Tet r a h yd r o-1H -â-ca r b olin -1-yl)a cet a -
m id e (8). Compound 8 was prepared analogously to
compound 2 using 160 mg (1 mmol) of tryptamine 101
mg (1.2 mmol) of cyanoacetamide and 21 mg (0.02
mmol) of 10% Pd‚C. After hydrogenation (48 h), com-
pound 8 was isolated as a solid (133 mg, 58%). 8: mp
196-197 °C; UV (MeOH) λmax 280, 232 nm; IR (KBr)
νmax 3439, 3214, 3048, 2951, 1677, 1451, 1413, 1314,
1257, 743 cm-1; EIMS m/ z 229 [M]+ (29), 184 (9), 171
(100), 156 (25), 144 (15), 130 (18), 115 (12); anal. C
67.64%, H 6.39%, N 18.08%, calcd for C13H15N3O, C
1
68.1%, H 6.59%, N 18.32%; H NMR (DMSO) δ 2 .38-
2.48 (1H, m), 2.55-2.64 (2H, m), 2.68 (1H, dd, J ) 4.5,
14.5 Hz), 2.83-2.96 (1H, m), 3.09-3.19 (1H, m), 3.32
(2H, s), 4.3 (1H, dd, J ) 3.4, 9 Hz), 6.92 (1H, s), 6.94-
7.06 (2H, m), 7.29 (1H, d, J ) 8 Hz), 7.47 (1H, d, J ) 8
Hz), 7.56 (1H, s); 13C NMR (CDCl3) δ 21.0, 39.0, 41.2,
49.3, 107.9, 111.1, 117.8, 119.0, 121.6, 126.5, 132.8,
135.8, 174.7.
2-(2,3,4,9-Tet r a h yd r o-1H -â-ca r b olin -1-yl)et h yl-
a m in e (9). Compound 9 was obtained by the procedure
used for the preparation of 4, using 1.2 g (32 mmol) of
LiAlH4 in 80 mL of THF, and 1.5 g (6.3 mmol) of amide
8, to afford 894 mg (64%) of amine 9: UV (MeOH) λmax
224, 279, 290 nm; IR (film) νmax 3394, 3259, 3057, 2937,
1574, 1469, 1319, 740 cm-1; EIMS m/ z 215 [M]+ (24),
198 (29), 185 (16), 171 (90), 160 (21), 156 (23), 144 (26),
130 (100); 1H NMR (CDCl3) δ 1.88 (2H, s), 2.6-2.72 (2H,
m), 2.8-3.1 (6H, m), 3.16-3.3 (1H, m), 4.05 (1H, t, J )
4.5 Hz), 7-7.12 (2H, m), 7.28 (1H, d, J ) 8 Hz), 7.44
(1H, d, J ) 8 Hz), 10 (1H, s); 13C NMR (CDCl3) δ 22.1,
35.4, 38.6, 42.1, 52.1, 107.9, 110.9, 117.8, 118.8, 120.9,
127.2, 135.4, 135.6.
Na zlin in e (4). To a solution of LiAlH4 (177 mg, 4.66
mmol) in THF (15 mL) was added dropwise with stirring
a solution of 222 mg (0.93 mmol) of nitrile 2 in THF.
The mixture was heated to reflux for 4 h and cooled to
room temperature, and excess hydride was decomposed
by addition of moist THF. MgSO4 was added, the THF
solution was filtered, and the solid was washed with
THF. Evaporation of the THF solution gave an oil,
which was chromatographed on an alumina column, to
Oxoela eoca r p id in e (10). A solution of amine 9 (430
mg, 2 mmol) and methyl 3-formylpropionate (500 mg,
4 mmol) in benzene/MeOH (40:2) was left at room
temperature under N2 for 5 h. Then 3 mL of AcOH was
added and the reaction mixture was refluxed for 3 h.